• Contagion LiveContagion Live
  • CGTLive logoCGTLive logo
  • HCP Live
  • Neurology LiveNeurology Live
  • OncLiveOncLive
HCPLive - Clinical news for connected physicians
HCPLive - Clinical news for connected physicians
Spotlight
COVID-19Sickle Cell Disease
Clinical
View MoreADHDAllergyArterial DiseaseCardiologyDermatologyDiabetesGastroenterologyGeriatric MedicineInfectious DiseaseInflammationNeurologyPsychiatryPulmonologyRheumatology
Video Series
InsightsNews NetworkPeers & PerspectivesPost Conference Perspectives
News
Media
Medical World News
Peer Exchange
Podcasts
Videos
Webinars
Conferences
Conference Coverage
Conference Listing
PartnersCME/CE
Resources
Exclusive Content
Interactive Tools
Live Events
Press Release
Publications
Sponsored
Subscribe
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions

© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.

Spotlight
  • COVID-19
  • Sickle Cell Disease
ClinicalSee All >
  • ADHD
  • Allergy
  • Arterial Disease
  • Cardiology
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Geriatric Medicine
  • Infectious Disease
  • Inflammation
  • Neurology
  • Psychiatry
  • Pulmonology
  • Rheumatology
Video Series
  • Insights
  • News Network
  • Peers & Perspectives
  • Post Conference Perspectives
hcplive podcasts
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.

Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

EP. 1: Overview of Polyvascular Disease and Coronary Artery Disease

April 29th 2022

Drs Marc Bonaca and Manesh Patel provide an overview of Polyvascular Disease and prevalence of coronary artery disease and peripheral artery disease.

EP. 2: Screening for Polyvascular Disease

April 29th 2022

Dr Amy Pollak and other experts discuss their recommendations for screening for CAD and PAD in asymptomatic patients.

EP. 3: Provider Engagement and Screening

May 6th 2022

Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.

EP. 4: Guidelines and Management of Patients With Polyvascular Disease

May 6th 2022

Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.

Latest News

Family History of OSA Contributes to Pathogenesis of the Condition

Significant OSA Prevalence in Pediatric Patients with Pulmonary Hypertension

Severe Asthma Exacerbation Risk Reduced with Combined Albuterol-Budesonide

View More News